Kimberly-Clark Positioned as Value Alternative to High-Valuation Retail Giants

Investors seeking exposure to consumer staples are increasingly weighing the trade-off between the growth profiles of retail giants and the income stability of traditional 'Dividend Kings.' Costco (COST) and Walmart (WMT) have delivered exceptional five-year total returns of 190% and 191%, respectively, significantly outpacing the S&P 500. However, this performance has led to significant valuation expansion. Walmart and Costco currently feature forward price-to-earnings (P/E) ratios of 43.4 and 48.7, which are more than double the S&P 500's forward P/E of 21.2. This pricing has compressed their dividend yields to 0.8% for Walmart and 0.5% for Costco, making them less attractive for yield-seeking portfolios. In contrast, Kimberly-Clark (KMB) presents a value-oriented alternative with a 5.3% dividend yield and a 54-year history of consecutive payout increases. While the company faces pressure from the private-label brands championed by Walmart and Costco, it is taking aggressive steps to diversify its product offerings. To mitigate the threat of generic household products, Kimberly-Clark is pursuing the acquisition of Kenvue, announced in November 2025 and expected to close in the second half of 2026. This move will integrate high-equity brands such as Tylenol, Listerine, and Neutrogena into its portfolio, shifting the company toward a broader household and personal care powerhouse. While the retail giants continue to benefit from massive scale—with Walmart reporting $713 billion in trailing-12-month sales—the current valuation gap makes Kimberly-Clark a compelling option for traders prioritizing immediate income and lower entry multiples over aggressive growth.